Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Grange

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialB G M Hughes, E Munoz-Couselo, L Mortier, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285]B G M Hughes, E Munoz-Couselo, L Mortier, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
The British Journal of Dermatology|March 6, 2019
Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance DatabaseL Dequidt, N Franck, P Sanchez-Pena, et al.
Blood|March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious LymphomasB Vergier, A de Muret, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialB G M Hughes, E Munoz-Couselo, L Mortier, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285]B G M Hughes, E Munoz-Couselo, L Mortier, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
The British Journal of Dermatology|March 6, 2019
Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance DatabaseL Dequidt, N Franck, P Sanchez-Pena, et al.
Blood|March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious LymphomasB Vergier, A de Muret, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Pageof 13